EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vitiligo: Pathogenesis and New and Emerging Treatments

Javier Perez-Bootello iD, Ruth Cova-Martin, Jorge Naharro-Rodriguez iD, Gonzalo Segurado-Miravalles

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242417306 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Javier Perez-Bootello und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ramon y Cajal University Hospital, Road M-607, 9, 100, 28034 Madrid, Spain. Hauptthemen laut MEDLINE: Vitiligo, Janus Kinase Inhibitors. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitiligo is a complex disease with a multifactorial nature and a high impact on the quality of life of patients. Although there are multiple therapeutic alternatives, there is currently no fully effective treatment for this disease. In the current era, multiple drugs are being developed for the treatment of autoimmune diseases. This review assesses the available evidence on the pathogenesis of vitiligo, and a comprehensive review of treatments available for vitiligo now and in the near future is provided. This qualitative analysis spans 116 articles. We reviewed the mechanism of action, efficacy and safety data of phototherapy, afamelanotide, cyclosporine, phosphodiesterase 4 inhibitors, trichloroacetic acid, basic fibroblast growth factor, tumor necrosis factor (TNF) inhibitors, secukinumab, pseudocatalase and janus kinase (JAK) inhibitors. At the moment, there is no clearly outstanding option or fully satisfactory treatment for vitiligo, so it is necessary to keep up the development of new drugs as well as the publication of long-term effectiveness and safety data for existing treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoJanus Kinase InhibitorsHumansQuality of LifePhototherapyTreatment Outcome

Stichwörter der Autor:innen

JAK inhibitorpathogenesistherapeuticsvitiligo

Substanzen

Janus Kinase Inhibitors

Autor:innen und Institutionen

  • Ramon y Cajal University Hospital, Road M-607, 9, 100, 28034 Madrid, Spain.

ORCID-Profile: Javier Perez-Bootello, Jorge Naharro-Rodriguez

Zitieren

APA

Perez-Bootello, J., Cova-Martin, R., Naharro-Rodriguez, J., & Segurado-Miravalles, G. (2023). Vitiligo: Pathogenesis and New and Emerging Treatments. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417306

Vancouver

Perez-Bootello J, Cova-Martin R, Naharro-Rodriguez J, Segurado-Miravalles G. Vitiligo: Pathogenesis and New and Emerging Treatments. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417306

BibTeX
@article{PerezBootello2023,
  author = {Perez-Bootello, Javier and Cova-Martin, Ruth and Naharro-Rodriguez, Jorge and Segurado-Miravalles, Gonzalo},
  title = {Vitiligo: Pathogenesis and New and Emerging Treatments},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242417306}
}
Kostenlos starten →